surmount-1 tirzepatide non-diabetic obesity trial for maintenance of bodyweight reduction in people with in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled Tirzepatide after intensive lifestyle intervention

"You'd think that would be a basic question because how do you know what the true market is if you haven't even asked how big it is?" Rosebush says

Still, telehealth providers also have to be sure their prescriptions are right for both medical and legal reasons

Some peoples bodies do not respond to the medication until they reach a higher dose, so if your weight loss has stalled, you should speak with your doctor about whether an increase is safe for you

In addition, 81.6% (10 mg) and 86.4% (15 mg) of people taking tirzepatide achieved at least 5% body weight reduction, the other co-primary endpoint, compared to 30.5% of those taking placebo

Which one should I take, Ozempic or Mounjaro? I get this question every day: in my inbox, in my exam room, in my DMs

Kothare PA, Linnebjerg H, Skrivanek Z, et al